Literature DB >> 7728395

Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus.

E J Davies1, G Steers, W E Ollier, D M Grennan, R G Cooper, E M Hay, M C Hillarby.   

Abstract

The objective of this study was to reassess the role of C4A null alleles in systemic lupus erythematosus (SLE) susceptibility after taking into account the association of DQA*0501 with this disease. The frequency of C4A null alleles in 82 SLE patients and 59 controls was determined using both immunofixation and a TaqI RFLP method. HLA-DQA and DQB alleles were identified by sequence-specific oligonucleotide typing. Empirical logistic analysis was used to assess the interactive effects of C4 and DQA alleles. It was found that the strongest association with SLE was for the combination of DQA*0501 and C4A*Q0 [odds ratio (OR) = 5.4, 95% confidence interval (CI) 2.5-11.7]. Both DQA*0501 (P = 0.02) and C4A*Q0 (P = 0.03) appeared to have significant individual effects on SLE susceptibility, with a significant statistical interaction between the two loci (P = 0.01). However, when anti-La antibody negative patients were examined only C4A*Q0 had a significant individual effect (P = 0.04). A significant statistical interaction between DQA*0501 and C4A*Q0 was again detected (P = 0.02). These results support the hypothesis that susceptibility to SLE is influenced by several genes with differing functions: HLA-DQA*0501 may predispose to autoantibody formation while C4A*Q0 impairs immune complex clearance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728395     DOI: 10.1093/rheumatology/34.3.221

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  7 in total

Review 1.  Recent advances in the genetics of systemic lupus erythematosus.

Authors:  Donna L Thibault Flesher; Xin Sun; Timothy W Behrens; Robert R Graham; Lindsey A Criswell
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

2.  Genetics of the type I interferon pathway in systemic lupus erythematosus.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  Int J Clin Rheumtol       Date:  2013-12-01

3.  Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

Authors:  M A Dragon-Durey; N Rougier; J P Clauvel; S Caillat-Zucman; P Remy; L Guillevin; F Liote; J Blouin; F Ariey; B U Lambert; M D Kazatchkine; L Weiss
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

4.  HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus.

Authors:  Antoni Hrycek; Urszula Siekiera; Paweł Cieślik; Witold Szkróbka
Journal:  Rheumatol Int       Date:  2004-09-21       Impact factor: 2.631

Review 5.  Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  J Autoimmun       Date:  2015-08-29       Impact factor: 7.094

6.  Association between copy number variation of complement component C4 and Graves' disease.

Authors:  Yu-Huei Liu; Lei Wan; Chwen-Tzuei Chang; Wen-Ling Liao; Wen-Chi Chen; Yuhsin Tsai; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2011-09-26       Impact factor: 8.410

Review 7.  Risk for rheumatic disease in relation to ethnicity and admixture.

Authors:  M Molokhia; P McKeigue
Journal:  Arthritis Res       Date:  2000-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.